Bone is a target for the antidiabetic compound rosiglitazone. (Q35758012)
scientific article published on 18 September 2003
Language:
(P31) (Q13442814)
(P50) (Q56473836)
(P304) 401-406
(P407) (Q1860)
(P433) 1
(P478) 145
(P577) Thursday, September 18, 2003
(P1433) (Q3054009)
(P1476) "Bone is a target for the antidiabetic compound rosiglitazone" (language: en)
(P2093) S O Rzonca
D Gaddy
D C Montague
B Lecka-Czernik
(P2860) (Q35127251)
(Q34835012)
(Q38361574)
(Q29617959)
(Q40731268)
(Q39753643)
(Q34469551)
(Q34371531)
(Q38297979)
(Q34311560)
(Q33947448)
(Q40761388)
(Q37271252)
(Q28140044)
(Q37242527)
(Q33983147)
(Q33934899)
(Q38322087)
(Q40941050)
(Q41055050)
(Q29547605)
(Q41150373)
(Q41155012)
(Q37353867)
(Q29615693)
(Q34018199)
(Q29616160)
(Q42538023)
(Q51625385)
(Q45730735)
(Q41621797)
(Q43783873)
(Q43782114)
(Q73193488)
(Q73085771)
(Q78258010)
(Q78854437)
(Q73663325)
(Q70619770)
other details
description scientific article published on 18 September 2003

External Links